他の暗号通貨に移動
INCYIncyte Corporation
Incyte Corporation
INCY重要なポイント
最終更新日時:: 2026-07-28- •IncyteのQ2非GAAP EPSは3.09ドルで予想を約0.94ドル上回り、収益は16.7億ドルで予想を約1.8億ドル上回った。これは現在のサイクルで最も大きな決算サプライズの一つ。
- •通期ガイダンスは一部アナリストの期待を下回ったものの、同社は売上見通しを引き上げた。これが、好決算にもかかわらず株価の反応が鈍い、あるいはわずかにネガティブになった理由である。
- •INCY CFDのレバレッジトレーダーは両建てのリスクに直面している。EPSの好調は上昇を支持するが、ガイダンス懸念がそれを抑制する。50倍レバレッジの場合、3%の変動は証拠金の150%のリターンまたは損失に相当する。
- •クロスマーケットへの影響はヘルスケア/バイオテクノロジーETF(XBI、XLV)に限定的。広範な指数(S&P 500、NASDAQ-100)への波及効果は最小限。
- •決算は好調だがガイダンスは下方修正というパターンは、2026年Q2決算シーズンで繰り返し見られるテーマである。レバレッジを追加する前に、ポジションサイジングの規律と決算後の値動きの確認が不可欠である。
価格と市場構造
取引レジームのステータス
用語集
Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.
| Stock CFD | A contract for difference on a share price — price exposure only, not ownership of the underlying shares. |
|---|---|
| Extended hours | Pre-market and after-hours trading outside the exchange’s regular session. |
| Basis risk | The risk that the CFD reference price and the exchange execution price do not move in step. |
| P/E | Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge. |
| Gross margin | Gross profit ÷ revenue; reflects product-level profitability. |
| EPS | Earnings per share = net income ÷ diluted shares outstanding. |
最新のパルス
Incyte Q2決算、EPSは予想を0.94ドル上回る3.09ドル、しかしガイダンス未達でCFD取引は両建ての様相
Incyte Corporation (NASDAQ: INCY) は、複数の市場情報源(MarketScreenerやInvesting.comなど)によると、Q2の非GAAP EPSが3.09ドルで、コンセンサス予想を約0.94ドル上回り、収益は16.7億ドルで、アナリスト予想を約1.8億ドル上回ったと発表しました。収益の好調さは注目に値します。コンセンサス予想はベンチマークによって14.2億
Incyte、Vega Therapeuticsを12.5億ドルで買収 — 血液疾患への注力でバイオテックM&Aの波を強化
Incyte Corporation (NASDAQ: INCY) は、Star Therapeutics社の企業創出プラットフォーム内で開発された、血液疾患に焦点を当てた非公開バイオテック企業であるVega Therapeuticsを、ヘッドライン考慮事項として12.5億ドルで買収すると発表しました。この取引は、Incyteの既存の血液腫瘍学および炎症性疾患事業に隣接する希少出血性疾患を対象とし
Incyteの約20億ドルのStar Therapeutics買収劇:レバレッジシナリオとバイオテクノロジーM&Aの示唆
Financial Timesの報道によると、Incyte Corporation (INCY) は、血液疾患治療薬開発企業であるStar Therapeuticsを約20億ドルで買収する契約締結に向けて最終調整に入っています。現時点では両社から正式な発表はありませんが、FTの情報源(通常は関係者からの情報に基づく)はイベントドリブン市場において高い信憑性を持つと見なされています。Star The
Get Started with Incyte Corporation
Start trading Incyte Corporation on CoinUnited.io with industry-leading leverage and zero fees.
Trade with Leverage
Trade INCY CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Zero trading fees
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade Incyte Corporation: Step-by-Step Guide
Learn how to trade Incyte Corporation (INCY) on CoinUnited.io with up to 1000x leverageand zero trading fees. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find INCY in the Stocks Section
Navigate to the stocks market section and search for INCY. You can trade Incyte Corporation as a CFD with up to 1000x leverage.
- ✓Search for "INCY" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade Incyte Corporation.
- ✓Long (buy) if you expect INCY to rise
- ✓Short (sell) if you expect INCY to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
タグ
Similar Stocks Assets
Explore other stocks instruments in the same sector as Incyte Corporation. Compare performance and find trading opportunities.

Tempus AI, Inc

Estee Lauder

Hecla Mining Company

Coeur Mining, Inc.

Kinross Gold Corporation
免責事項および参考文献
重要なリスク免責事項
A CoinUnited stock CFD gives price exposure to Incyte Corporation only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.
Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.
投資判断を行う前には、利用者ご自身で十分な調査を行い、信頼できる金融専門家に相談することを推奨します。本プラットフォームの作成者および運営者は、提供された情報に依拠したことにより発生した金融損失やその他の損害について、一切の責任を負いかねます。
Leveraged trading is extremely risky and you may lose your entire deposit.
方法論の概要
Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.
- Financial statements: the company’s own SEC filings (10-K / 10-Q), read from XBRL
- Market data: the CoinUnited reference price and daily closes
- Institutional ownership: SEC Form 13F quarterly filings
- Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited’s view
- Peer multiples: third-party trailing-twelve-month ratios
CoinUnited does not publish a price forecast or target for Incyte Corporation.
最新の方法論の見直し:
Incyte Corporationの取引を始める準備はできましたか?
何千人ものトレーダーに参加し、今日からIncyte Corporationの取引を始めましょう。高度な取引ツールと競争力のある手数料にアクセスできます。




